$12 million seed funding round led by Oxford Science Enterprises and Apollo Health Ventures, with AlbionVC, YZR Capital, and Parkwalk Advisors, and support from Oxford University Innovation Scripta ...
Australians living with a range of debilitating conditions including juvenile arthritis, rare liver disease and multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback